Many Medicare beneficiaries do not fill high-price specialty drug prescriptions, particularly those that do not receive a low-income subsidy. Stacie Dusetzina, PhD, Russell Rothman, MD, MPP, and colleagues found that beneficiaries receiving subsidies were twice as likely to obtain the prescribed drug than those not receiving subsidies, demonstrating the need to increase the accessibility of high-price medications by reducing out-of-pocket expenses under Medicare Part D.
Russell Rothman, MD, MPP and colleagues received funding approval for the The Stakeholders, Technology and Researchers Clinical Research Network (STAR CRN), supporting the next phase of the National Patient-Centered Clinical Research Network (PCORnet). The objective of this CRN is to support projects in comparative effectiveness research, pragmatic clinical trials, and other research areas
HERO-TOGETHER is an opportunity for people working in health care who receive a COVID-19 vaccine to help the public understand how people do after vaccination. The COVID-19 pandemic is a once-in-a-generation challenge that health care heroes everywhere have worked together to face. From working on the front lines to working behind the scenes, people in healthcare and public service have joined together with unprecedented focus to fight COVID-19.
Vanderbilt University Medical Center is playing a key role in a national effort to establish a registry of U.S. health care workers and test whether the anti-malarial drug hydroxychloroquine (HCQ) will protect them, their patients and their families from COVID-19. The Board of Governors of the non-profit Patient-Centered Outcomes Research Institute (PCORI) in Washington, D.C., today approved up to $50 million to fund the initiative, known as the Healthcare Worker Exposure Response and Outcomes (HERO) research program, to be led by the Duke Clinical Research Institute (DRCI). Co-chairs of the HERO Steering Committee are Russell Rothman, MD, MPP, VUMC Senior Vice President for Population and Public Health, and Judith Currier, MD, professor of Medicine and chief of the Division of Infectious Diseases at UCLA Medical Center, Santa Monica. Fellow steering committee member Sean Collins, MD, MSCI, professor and executive vice chair of the Department of Emergency Medicine at VUMC, will lead VUMC’s engagement in the HERO study and will serve as the site’s principal investigator. He also is a member of the protocol advisory committee.
Russell Rothman, MD, MPP, professor of Internal Medicine, Pediatrics and Health Policy, Ingram Professor of Integrative and Population Health, and Vice President for Population Health Research, has been named as the new director of the Institute for Medicine and Public Health (IMPH), and Senior Vice President for Population and Public Health. His appointment is effective Feb. 1. In this new role Rothman will report to Jennifer Pietenpol, PhD, Executive Vice President for Research and Director of the Vanderbilt-Ingram Cancer Center. Rothman is also principal investigator of the Patient Centered Outcomes Research Institute (PCOR) funded STAR (Stakeholders, Technology and Research) Clinical Research Network which engages VUMC, VHAN, Meharry Medical College, Duke University, the University of North Carolina, Wake Forest University, Health Sciences of South Carolina, and Mayo Clinic with electronic health records on over 12 million patients. The Network supports real world evidence research and pragmatic clinical research.